Royalty Pharma plc (RPRX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $9.91B | +25.7% |
| 2024 | $7.88B | +25.1% |
| 2023 | $6.30B | -13.6% |
| 2022 | $7.29B | +0.3% |
| 2021 | $7.27B | +18.7% |
| 2020 | $6.12B | -2.9% |
| 2019 | $6.31B | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $9.91B | +25.7% |
| 2024 | $7.88B | +25.1% |
| 2023 | $6.30B | -13.6% |
| 2022 | $7.29B | +0.3% |
| 2021 | $7.27B | +18.7% |
| 2020 | $6.12B | -2.9% |
| 2019 | $6.31B | — |